CDK4 and atherosclerosis: Our results showed that ginsenoside Rb1 significantly inhibited the proliferation of vascular cells by inhibiting the interaction of CCDN1 and CDK4, which will provide useful insights for developing novel anti-atherosclerosis drugs by inhibiting cell proliferation.